tirzepatide children type 2 diabetes Big update in pediatric diabetes care ๐ฉบ Mounjaroยฎ (tirzepatide) is now LLY -0.60% today as Lilly's
Description
[DOI] [PubMed] [Google Scholar] 6.Sun B., Willard F
Injection night: Light dinner finished 2 hours before injection
Compounded tirzepatide itself is not FDA-approved, but it can be legally prepared by licensed compounding pharmacies
Reported side effects in pediatric patients are consistent with those observed in adults, although rates of vomiting, abdominal pain, and hypoglycemia appear to be higher in the pediatric population
The results are expected to be available in 2026
:format(webp))
Ideal sublingual candidates are small (under 1,000 daltons), lipophilic (able to cross cell membranes easily), and require low doses
